Genzyme Recalls Three Lots of Transplant Drug, FDA Says

Genzyme Corp. voluntarily recalled three lots of Thymoglobulin, a drug used during transplants, after the solution was found to have a different appearance than usual, the Food and Drug Administration said on its website.
The Wall Street Journal